CN109415378A - 水溶性Epothilone衍生物及其制备方法 - Google Patents

水溶性Epothilone衍生物及其制备方法 Download PDF

Info

Publication number
CN109415378A
CN109415378A CN201780027084.XA CN201780027084A CN109415378A CN 109415378 A CN109415378 A CN 109415378A CN 201780027084 A CN201780027084 A CN 201780027084A CN 109415378 A CN109415378 A CN 109415378A
Authority
CN
China
Prior art keywords
compound
added
formula
epothilone
compound represented
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201780027084.XA
Other languages
English (en)
Other versions
CN109415378B (zh
Inventor
汪海波
况洪福
张伟
郑晓鹤
朱天民
杨志清
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Hisun Pharmaceutical Co Ltd
Original Assignee
Zhejiang Hisun Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Hisun Pharmaceutical Co Ltd filed Critical Zhejiang Hisun Pharmaceutical Co Ltd
Priority claimed from PCT/CN2017/080254 external-priority patent/WO2017193757A1/zh
Publication of CN109415378A publication Critical patent/CN109415378A/zh
Application granted granted Critical
Publication of CN109415378B publication Critical patent/CN109415378B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

提供水溶性的通式(I)所示的Epothilone衍生物、制备方法及其中间体,以及它们在制备抑制肿瘤细胞生长的药物中的应用。

Description

PCT国内申请,说明书已公开。

Claims (13)

  1. PCT国内申请,权利要求书已公开。
CN201780027084.XA 2016-05-10 2017-04-12 水溶性Epothilone衍生物及其制备方法 Active CN109415378B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201610307285 2016-05-10
CN2016103072852 2016-05-10
PCT/CN2017/080254 WO2017193757A1 (zh) 2016-05-10 2017-04-12 水溶性Epothilone衍生物及其制备方法

Publications (2)

Publication Number Publication Date
CN109415378A true CN109415378A (zh) 2019-03-01
CN109415378B CN109415378B (zh) 2021-11-09

Family

ID=65463380

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201780027084.XA Active CN109415378B (zh) 2016-05-10 2017-04-12 水溶性Epothilone衍生物及其制备方法

Country Status (1)

Country Link
CN (1) CN109415378B (zh)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1217662A (zh) * 1996-03-12 1999-05-26 Pg-Txl有限公司 水溶性紫杉醇产品

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1217662A (zh) * 1996-03-12 1999-05-26 Pg-Txl有限公司 水溶性紫杉醇产品

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
WANG, HAI-BO等: "Synthesis and Evaluation of A Water-Soluble Epothilone B Prodrug with Remarkably Decreased Toxicity", 《LETTERS IN ORGANIC CHEMISTRY》 *
张海艳等: "聚乙二醇修饰埃坡霉素B偶联物的合成及其体外抗肿瘤作用", 《国际药学研究杂志》 *
汪海波等: "PEG-Epothilone B的合成及其初步抗肿瘤活性研究", 《中国医药工业杂志》 *
王堃: "埃博霉素B的制备分析及PEG修饰", 《中国优秀硕士学位论文全文数据库 医药卫生科技辑》 *
黄宪等编著: "《新编有机合成化学》", 31 January 2003 *

Also Published As

Publication number Publication date
CN109415378B (zh) 2021-11-09

Similar Documents

Publication Publication Date Title
US20190358219A1 (en) Ternary conjugate of antitumor drug, and synthesis and application
EP3838893B1 (en) Linker, antibody-drug conjugate including same, and use thereof
CN101812059B (zh) 一氧化氮供体型法尼基硫代水杨酸衍生物、其制备方法及其医药用途
EP4227309A1 (en) Deuterated camptothecin derivative and antibody-drug conjugate thereof
WO2013186384A1 (en) N-substituted second generation derivatives of antifungal antibiotic amphotericin b and methods of their preparation and application
CA3083056A1 (en) A double-labeled probe for molecular imaging and use thereof
CN101084234A (zh) 作为抗癌药剂的桦木醇衍生物
Cong et al. Conjugating 4β‐NH‐(5‐Aminoindazole)‐podophyllotoxin and Galectin‐1‐Targeted Aptamer for Synergistic Chemo‐Immunotherapy of Hepatocellular Carcinoma
CN105012307B (zh) Imb5046化合物在制备抗肿瘤药物中的用途
CN110522923A (zh) 果糖和rgd肽共修饰的双重靶向三阴性乳腺癌的脂质材料
CN109415378A (zh) 水溶性Epothilone衍生物及其制备方法
CN110917139A (zh) 多分枝生物素修饰的乳腺癌靶向脂质体的制备和应用
EP3431478B1 (en) Micromolecular lung-targeting drug
CN103183722B (zh) 一种乙二醛酶i抑制剂及其制备方法和医药用途
BR112020009737A2 (pt) composições estáveis de compostos de carfilzomib peguilados
TWI771652B (zh) Cd44靶向多臂偶聯物
US10512627B2 (en) Anti-tumor compound and the medical use thereof
CN111393368B (zh) 一种茚并吡唑盐酸盐类衍生物及其制备方法与应用
CN107949566B (zh) 水溶性雷帕霉素类衍生物
CA2973380A1 (en) Cancer imaging agent
CN114573459B (zh) β-榄香烯双胺基取代衍生物及其制备方法和应用
CN109734692B (zh) 一种具有egfr激酶抑制活性的白杨素亮氨酸衍生物
WO2017193757A1 (zh) 水溶性Epothilone衍生物及其制备方法
WO2024012157A1 (zh) 一种多肽类化合物及其配合物、应用
CA3210863C (en) Truncated evans blue modified fibroblast activation protein inhibitor, preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant